Dipatimenti Yapadziko Lonse

CT011 ndi mankhwala a GPC3 CAR T-cell omwe amagwiritsidwa ntchito pochiza khansa ya chiwindi (HCC). CT011 idalandira chilolezo cha IND kuchokera ku NMPA mu 2019 kuti ichiritse odwala omwe ali ndi chotupa cholimba cha GPC3-positive chomwe chinali chilolezo choyamba cha IND ku China cha chithandizo cha maselo a CAR T motsutsana ndi cholimba ...Werengani zambiri»

Pulofesa wa ku yunivesite ya ku Russia wazaka za m'ma 70 ali ndi matenda a multiple myeloma. Atalandira chithandizo chambiri komanso kubwereranso kawiri kwa opaleshoni ya autologous, adaphunzira za chithandizo chamakono chothana ndi khansa cha CAR-T ku China, kotero adabwera ku China kudzalandira maselo a CAR-T...Werengani zambiri»

Pa Julayi 20, New Drug Application (NDA) ya pCAR-19B yopangidwa payokha ndi Precision Biology idavomerezedwa mwalamulo ndi China National Medical Products Administration (NMPA). Mankhwalawa ndi mankhwala oyamba a CAR-T a khansa ya m'magazi ya ana ku China, omwe amagwiritsidwa ntchito pochiza odwala azaka zapakati pa 3-21 ...Werengani zambiri»

Satricabtagene autoleucel (Satri-cel, CT041) ndi mankhwala a autologous CAR T-cell omwe amatsutsana ndi puloteni ya Claudin18.2 yomwe ili ndi kuthekera kokhala pamwamba padziko lonse lapansi. Satri-cel imayang'ana kwambiri zotupa zolimba za Claudin18.2 zomwe zimayang'ana kwambiri khansa ya m'mimba/gastroesophageal junction...Werengani zambiri»

Pa Seputembala 6, 2021, JW Therapeutics yalengeza kuti National Medical Products Administration (NMPA) ya ku China yavomereza New Drug Application (NDA) ya anti-CD19 autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product relmacabtagene autoleucel injection (relma-cel) ...Werengani zambiri»

Equecabtagene autoleucel (eque-cel), chithandizo cha maselo a T-cell opangidwa ndi anthu chochokera ku B-cell maturation antigen-targeting chimeric antigen receptor (CAR), chawonetsa kuthekera kochizira matenda a relapse or refractory multiple myeloma (R/RMM). Pa June 30, 2023, China’s National Medical Products Admi...Werengani zambiri»

Pa Okutobala 11, 2024, bungwe la National Medical Products Administration (NMPA) la ku China lavomereza kugwiritsa ntchito mankhwala atsopano (IND) a Inaticabtagene Autoleucel (CNCT19 Injection), chithandizo cha maselo a CD19-target autologous chimeric antigen receptor (CAR)-T, pochiza matenda a thrombocytopenia ...Werengani zambiri»

Pa 1 Marichi, 2024, bungwe la China National Medical Products Administration (NMPA) linavomereza kuyambitsidwa kwa mankhwala a maselo a CAR-T Zevorcabtagene AutoLeucel (Zevor-cel, CT053) kuti athandize odwala akuluakulu omwe ali ndi matenda a myeloma ambiri omwe adachira kapena omwe adachira pambuyo pa njira zitatu zochiritsira (...Werengani zambiri»